SIIA Joins US Chamber and PhRMA in Amicus Brief to The Supreme Court

SIIA joins the U.S. Chamber of Commerce and PhRMA (the Pharmaceutical Research and Manufacturers of America) in an amicus brief to the U.S. Supreme Court urging them to rein in class action lawsuits. SIIA, the Chamber and PhRMA have a strong interest in ensuring courts do not certify class actions that improperly include significant numbers of uninjured class members: a significant problem for SIIA members and others who face claims of intangible injury in privacy and other similar lawsuits. The brief asks the Court to clarify Rule 23’s requirements and direct lower courts to stop bending the rules in favor of class certification. Read the full brief here.

Comments are closed.